Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and
Severe Acute Respiratory Syndrome
Allometric model shows human travel is closely related to spread of COVID-19
A new study, released on the medRxiv* preprint server, indicates that the spread of the
Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study
Although monoclonal antibodies (mAbs) are an effective treatment option against the severe acute respiratory syndrome
Alpaca nanobodies effective against South African SARS-CoV-2 variant
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants
RNA-binding cylinders inhibit SARS-CoV-2 replication in vitro
Research led by Michael J. Hannon from the University of Birmingham, UK, finds metallo-supramolecular helicates
Glycans influence SARS-CoV-2 spike–ACE2 binding affinity, finds study
A study conducted at the Los Alamos National Laboratory, USA, and Concordia University, Canada, has
Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals
The search for effective and safe antivirals against the severe acute respiratory syndrome coronavirus 2
A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice
A Korea-based company EyeGene Inc. has recently developed a liposome-based mRNA candidate vaccine against coronavirus
Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds
As the coronavirus disease (COVID-19) pandemic continues, scientists race to develop or find effective treatments
SARS-CoV-2 spike stimulates hyperinflammation via Toll-like receptor 2
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2